Table 3.

Net reclassification improvement based on serum T50

Without serum T50aWith serum T50
<5%5%–10%>10%Total (n)
Patients with all-cause mortalityb,c
 <5%44d8
 5%–10%94d13
 >10%3e5760
 Total4166181
Patients without all-cause mortalityb,c
 <5%17617e193
 5%–10%43d9022e155
 >10%3d40d225268
 Total222147247616
  • a Multivariable model including recipient age and gender and eGFR (CKD-EPI).

  • b Net reclassification improvement was 14%, P=0.002.

  • c 697 RTR were included in this analysis.

  • d Numbers of patients who were correctly reclassified by the model with serum T50.

  • e Numbers of patients who were incorrectly reclassified by the model with serum T50.